Fujifilm Diosynth Biotechnologies' bet on its North Carolina biologics facility is paying off, as Regeneron plans to shell ...

Matter Bio, co-founded by George Church, partners with scientists to study longevity genes in centenarians and long-lived ...

Pharma companies stockpile drugs in US ahead of expected Trump tariffs, while execs warn of R&D cuts and manufacturing ...

For the first time since the Trump administration's major staff cuts at the FDA this month, the agency publicly announced that the firings will lead to a long delay for what would otherwise be a ...

The XBI has plunged 27% since Donald Trump won the election, leaving the public markets an ugly mess for a biotech industry ...

Roche plans $50B investment in US over 5 years for R&D and manufacturing, including 4 new facilities and expansions, amid ...

AstraZeneca/Daiichi's Enhertu plus Perjeta shows better progression-free survival vs standard care in first-line HER2+ ...

Chinese biotech HuidaGene reports early success with first CRISPR brain treatment in 9-year-old with MECP2 duplication ...

Paul Stoffels joined Galapagos to turn it around three years ago. But after a series of unsuccessful studies, pipeline changes and a bumpy quest into cell therapy, the Belgian biotech's turnaround ...

Invivyd secures $30M loan facility from Silicon Valley Bank in three $10M tranches, ahead of FDA discussions about Covid-19 antibody VYD2311 ...

Superpower raises $30M Series A led by Forerunner to expand health testing service offering blood biomarker analysis and app access for $499/year ...

Alvogen plans to fight a court decision that could significantly delay its ability to bring a generic version of Bausch ...